Management of Rhinitis: Allergic and Non-Allergic
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
RHINITIS IS A GLOBAL PROBLEM AND IS DEFINED AS THE PRESENCE OF AT LEAST ONE OF THE FOLLOWING: congestion, rhinorrhea, sneezing, nasal itching, and nasal obstruction. The two major classifications are allergic and nonallergic rhinitis (NAR). Allergic rhinitis occurs when an allergen is the trigger for the nasal symptoms. NAR is when obstruction and rhinorrhea occurs in relation to nonallergic, noninfectious triggers such as change in the weather, exposure to caustic odors or cigarette smoke, barometric pressure differences, etc. There is a lack of concomitant allergic disease, determined by negative skin prick test for relevant allergens and/or negative allergen-specific antibody tests. Both are highly prevalent diseases that have a significant economic burden on society and negative impact on patient quality of life. Treatment of allergic rhinitis includes allergen avoidance, antihistamines (oral and intranasal), intranasal corticosteroids, intranasal cromones, leukotriene receptor antagonists, and immunotherapy. Occasional systemic corticosteroids and decongestants (oral and topical) are also used. NAR has 8 major subtypes which includes nonallergic rhinopathy (previously known as vasomotor rhinitis), nonallergic rhinitis with eosinophilia, atrophic rhinitis, senile rhinitis, gustatory rhinitis, drug-induced rhinitis, hormonal-induced rhinitis, and cerebral spinal fluid leak. The mainstay of treatment for NAR are intranasal corticosteroids. Topical antihistamines have also been found to be efficacious. Topical anticholinergics such as ipratropium bromide (0.03%) nasal spray are effective in treating rhinorrhea symptoms. Adjunct therapy includes decongestants and nasal saline. Investigational therapies in the treatment of NAR discussed include capsaicin, silver nitrate, and acupuncture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
The diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096 · cited 10×
“European guidelines recommend a maximum of 10 days use.(1,2)”
BackgroundInfluentialThe burden of allergic rhinitis
Nathan, R. A. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap.2007.28.2934 · Cited by 472
Allergic rhinitis: Direct and indirect costs
Blaiss, M. S. (2010) · Allergy and Asthma Proceedings · doi:10.2500/aap.2010.31.3329 · Cited by 220
Self-citationUpdate on nonallergic rhinitis
Settipane, R. A., & Lieberman, P. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62896-7 · Cited by 206 · cited 2×
“It has been used intranasal to try and decrease nasal hyperreactivity responsible for rhinorrhea, sneezing, and congestion.(37) A placebo-controlled studies using intranasal capsaicin in patient with nonallergic, noninfectious perennial rhinitis found a significant and long-term reduction in the visual analogue scale…”
BackgroundThe Pathophysiology, Diagnosis and Treatment of Allergic Rhinitis
Min, Y.-G. (2010) · Allergy, Asthma and Immunology Research · doi:10.4168/aair.2010.2.2.65 · Cited by 188 · cited 1×
“world.(6) In the United States it affects between 10-30% of the adult general population and up to 40% of children.”
BackgroundEfficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis
Banov, C. H., & Lieberman, P. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62352-6 · Cited by 135 · cited 2×
“Of the two topical antihistamines on the market in the United States (azelastine and olopatadine), azelastine is the only one that has been shown to be efficacious for nonallergic rhinitis.(1,32,34) Banov and Lieberman(32) evaluated the efficacy of the azelastine nasal spray in patients with nonallergic vasomotor rhin…”
Background
Cited by
Clinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
Clinical Practice Guideline: Allergic Rhinitis Executive Summary
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814562166 · Cited by 188
Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report
Papadopoulos, N. G., Bernstein, J. A., Demoly, P., Dykewicz, M., Fokkens, W., Hellings, P. W., Peters, A. T., Rondon, C., Togias, A., & Cox, L. S. (2015) · Allergy · doi:10.1111/all.12573 · Cited by 182
“rhinitis • Symptoms: Obstruction, rhinorrhea, sneezing, and pruritus • Seasonal symptoms (58), preponderance of sneezing and pruritus (48) • Family history of atopy (8) • Early onset (<age 20) • Concurrent allergic conjunctivitis (6), atopic dermatitis, asthma (79, 293), food allergy (58), and obstructive sleep apnea…”
BackgroundInfluential
Metadata
- Authors
- Tran, N. P., Vickery, J., & Blaiss, M. S.
- Venue
- Allergy, Asthma and Immunology Research
- Publisher
- The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al
- Published
- 2011
- Volume
- 3
- Issue
- 3
- Pages
- 148
- ISSN
- 2092-7355 (ISSN-L)
- OpenAlex
- W2113429067
- Cited by
- 203
- References
- 8
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Rhinitis: Allergic and Non-Allergic. https://app.cochat.ai/papers/10.4168/aair.2011.3.3.148
- The paper
- Tran, N. P., Vickery, J., & Blaiss, M. S. (2011). Management of Rhinitis: Allergic and Non-Allergic. Allergy, Asthma and Immunology Research. https://doi.org/10.4168/aair.2011.3.3.148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.